J.P. Morgan lowered forecasts for the U.S. and global knee and hip market, which means the third quarter forecasts for these companies is also low. The price target for Stryker decreased from $58 to $49, Zimmer from $63 to $58 and Wright from $21 to $17.
Read the Benzinga report on J.P. Morgan’s lowered forecasts.
Read other coverage on orthopedic device companies:
– VertiFlex Sells Silverbolt Product Portfolio to Exatech
– Stryker Acquires Gaymar Industries
– Medtronic Lowers Profit Forecast, Incurs Price Drop
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
